These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4665529)

  • 21. Dietary clofibrate inhibits induction of hepatic antioxidant enzymes by chronic estradiol in female ACI rats.
    Mesia-Vela S; Sanchez RI; Reuhl KR; Conney AH; Kauffman FC
    Toxicology; 2004 Aug; 200(2-3):103-11. PubMed ID: 15212807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New treatment option for decreasing blood cholesterol level--clinical significance of inhibition of both, cholesterol absorption and synthesis].
    Paragh G; Márk L; Czine Z
    Orv Hetil; 2004 Apr; 145(15):805-11. PubMed ID: 15188635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] lipid metabolism. II. Effects on the incorporation of various isotopic precursors in rat liver].
    Priego JG; Maroto ML; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):28-30. PubMed ID: 697397
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of pyridinolcarbamate on hepatic cholesterogenesis in rats.
    Kritchevsky D; Tepper SA
    Experientia; 1967 Dec; 23(12):1006-7. PubMed ID: 6077861
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of tiadenol, bis-(hydroxyethylthio)1,10-decane, on cholesterol metabolism in rats.
    Kritchevsky D; Tepper SA; Czarnecki SK; Story JA
    Pharmacol Res Commun; 1979 Nov; 11(10):861-7. PubMed ID: 538065
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of magnesium, potassium, antikaliuretic agents and hypocholesteremic agents in cardiac lesion development in rats fed a thrombogenic diet and Na 2 HPO 4 ].
    Savoie LL
    Pathol Biol (Paris); 1972 Oct; 20(19):751-6. PubMed ID: 4343433
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of clofibrate on plasma lipids of rat and rabbit.
    Byers SO; Friedman M
    Atherosclerosis; 1970; 11(3):373-82. PubMed ID: 5433083
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of Nicotinic Acid, ascorbic acid and 1-triiodothyronine on serum and liver cholesterol levels.
    Tantengco VO; Canlas BD; Somera LC; Hcredo E
    Acta Med Philipp; 1966; 3(1):1-12. PubMed ID: 5975614
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance.
    Catapano AL
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of N-cyclohexyl linoleamide on cholesterol synthesis by rat liver slices.
    Kritchevsky D; Tepper SA
    Can J Biochem; 1968 Nov; 46(11):1429-30. PubMed ID: 5687075
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inhibition of cholesterol biosynthesis in rabbit hepatocytes by 3-beta-(omega-hydroxyalkoxy)cholest-5-enes].
    Maliugin AV; Novikov DK; Kosykh VA; Kosenkov EI; Medvedeva NV; Valentinova NV; Shteĭnshneĭder AIa; Misharin AIu
    Bioorg Khim; 1996 Jul; 22(7):541-7. PubMed ID: 8992960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of selected hypolipidemic drugs on cell ultrastructure.
    Svoboda DJ; Azarnoff DL
    Fed Proc; 1971; 30(3):841-7. PubMed ID: 5575296
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mechanism of action of clofibrate].
    Lang PD
    Ther Ggw; 1975 Feb; 114(2):204-6, 208-10, 212-4. PubMed ID: 1118816
    [No Abstract]   [Full Text] [Related]  

  • 35. Amides of beta-(4-chlorophenoxy)-alpha-phenyl-ethylamines are inhibitors of cholesterol biosynthesis in vitro.
    Rossi S; Diamantini G; Pescador R
    Farmaco; 1989 Mar; 44(3):315-21. PubMed ID: 2775418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of low doses of nicotinic acid upon the development of lipid disturbances in rats chronically exposed to carbon disulphide.
    Wrońska-Nofer T
    Int Arch Arbeitsmed; 1972; 29(4):285-90. PubMed ID: 5049540
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of nicotinic acid on incorporation of 1-C14-acetate in cholesterol and liver protein in animals].
    Shushevich SI; Chagovets' RV
    Ukr Biokhim Zh; 1965; 37(6):895-901. PubMed ID: 5877236
    [No Abstract]   [Full Text] [Related]  

  • 38. The additive effects of clofibrate and probucol (DH-581) on rat serum cholesterol.
    Duncan CH; Best MM
    Atherosclerosis; 1973; 17(2):161-6. PubMed ID: 4709117
    [No Abstract]   [Full Text] [Related]  

  • 39. Observations on some pharmacologic properties of a new ester of the nicotinic acid: mesoinositol-pentanicotinate.
    Linari G
    Arzneimittelforschung; 1972 Aug; 22(8):1419-21. PubMed ID: 4678404
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypocholesterolemic effect of 4,4'-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (probucol).
    Barnhart JW; Sefranka JA; McIntosh DD
    Am J Clin Nutr; 1970 Sep; 23(9):1229-33. PubMed ID: 5450842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.